Company Number: 13515657

Analysis Date: 2025-07-20 16:27 UTC

Financial Health Assessment for MERAKIUN LIMITED

---

1. Financial Health Score: D

Explanation:
The company demonstrates clear symptoms of financial distress, including persistent net current liabilities, negative net assets, and shareholder funds. While the business is still active, these warning signs indicate an unhealthy financial state that requires urgent attention to avoid further deterioration.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets	£13,824	Stable fixed asset base; however, relatively low in value, indicating limited long-term resources.
Current Assets	£75	Extremely low liquidity; insufficient to cover near-term obligations.
Current Liabilities	£15,355	High short-term debts; pressure on cash flow to meet immediate financial commitments.
Net Current Assets	-£15,430	Negative working capital; indicates the company cannot pay its short-term debts with current assets.
Net Assets (Equity)	-£1,606	Negative equity; liabilities exceed total assets, reflecting an insolvent balance sheet position.
Shareholders’ Funds	£-1,606	Negative retained capital, showing accumulated losses or deficit in funding.
Director Loan Account	£14,452 owed	High director loan balance suggests reliance on personal funding to sustain operations.
Employee Count	Nil	No staff employed, indicating either a very small-scale operation or potential under-resourcing.

---

3. Diagnosis

The financial vital signs paint a picture of a company with symptoms of financial distress:

• The company’s liquidity is critically impaired, evidenced by a severe cash crunch (current assets £75 vs current liabilities £15,355). This is like a patient with dangerously low blood pressure—immediate intervention needed to restore stability.

• Negative working capital and net assets suggest the business is technically insolvent on a balance sheet basis. The negative net assets (-£1,606) mean the company owes more than it owns, a sign that creditors’ claims exceed the value of company resources.

• The director’s loan account (£14,452) acts as a vital lifeline, sustaining the company’s operations. This is akin to an IV drip keeping a patient alive but not curing the underlying condition.

• No employees are listed, which may indicate a lean operation but also risks insufficient capacity for growth or operational resilience.

• The company is classified as a Micro entity, so financial reporting requirements are minimal, but this also limits information available for deep analysis.

• The industry (leasing of intellectual property) may imply a business model dependent on intangible assets and royalties, which can have unpredictable cash flow patterns.

---

4. Recommendations

To improve financial wellness and move toward recovery, the company should consider the following actions:

a. Improve Liquidity and Working Capital

• Seek additional funding or equity injections to bolster current assets and cover short-term liabilities.
• Negotiate payment terms with creditors to stretch out liabilities and reduce immediate cash outflows.

b. Address Director Loan Balance

• Formalize repayment plans or convert part of the director loan into equity to strengthen the balance sheet and reduce financial risk.

c. Enhance Revenue Generation and Cash Flow

• Explore new licensing deals or intellectual property monetization strategies to generate consistent cash inflows.
• Review cost structure and eliminate non-essential expenses to preserve cash.

d. Monitor and Manage Financial Health Closely

• Prepare monthly cash flow forecasts to anticipate liquidity shortages early.
• Engage a financial advisor or turnaround specialist to implement a structured recovery plan.

e. Consider Strategic Options

• If recovery prospects are poor, explore restructuring, sale, or controlled wind-down to minimize losses.

---

Medical Analogy Summary

MERAKIUN LIMITED shows "symptoms" such as dangerously low liquidity ("weak pulse"), negative net assets ("underweight balance sheet"), and reliance on director funding ("life support"). Without swift action to stabilize finances ("emergency treatment"), the company risks "financial collapse."

---